Physician profile
Patrick Mufarrij
NPI 1992900526
$31,207.50
in general payments reported to CMS, 2019-2025
24 companies · $426 in 2025
The $426 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $4,841 · 2021: $3,115 · 2022: $1,170 · 2023: $906 · 2024: $1,568 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,898 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Education: $1.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,898.31 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Education | $1.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $18,626.47 | 2019-2025 | Thiola |
| Cook Incorporated | $3,500.00 | 2020 | |
| Gyrus Acmi, INC. | $3,456.17 | 2019 | |
| Cook Medical LLC | $2,629.12 | 2019-2025 | Litho 150, Fiber Dust, Cook |
| Coloplast Corp | $713.35 | 2021-2023 | Porges Coloplast |
| Olympus America INC. | $565.15 | 2020-2025 | Olympus, Soltive, Soltive |
| Astellas Pharma US INC | $444.46 | 2019-2024 | Myrbetriq |
| Richard Wolf Medical Instruments Corp. | $200.94 | 2019 | |
| Alnylam Pharmaceuticals INC. | $189.75 | 2020-2023 | Givlaari |
| Neotract INC. | $137.34 | 2019 | |
| Ambu INC. | $133.90 | 2023-2024 | |
| Boston Scientific Corporation | $121.90 | 2019 | |
| Ethicon INC. | $118.33 | 2020 | |
| Karl Storz Endoscopy-America | $88.40 | 2019 | |
| 180 Medical, INC. | $47.86 | 2019-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $41.75 | 2021-2022 | |
| Pfizer INC. | $33.37 | 2019 | |
| Merck Sharp & Dohme LLC | $29.50 | 2025 | Bridion |
| Telix Pharmaceuticals | $24.43 | 2024 | Illuccix |
| Teleflex LLC | $24.27 | 2025 | Barrigel |
| Mission Pharmacal Company | $22.79 | 2019 | |
| Palette Life Sciences, INC. | $20.50 | 2022 | |
| Amgen INC. | $19.74 | 2019 | |
| Hollister Incorporated | $18.01 | 2023 | Vapro, Infyna Chic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mufarrij listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.